---
schema_version: "secwatch.filing_event.v1"
accession: "0001656423-22-000018"
form_type: "8-K"
ticker: "BXP"
cik: "0001037540"
company_name: "BXP, Inc."
filed_at: "2022-05-02T23:59:59+00:00"
generated_at: "2026-06-26T01:52:32.829023+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Boston Properties Q1 EPS $0.91 beats guidance; FFO $1.82; acquires Seattle tower for ~$730M

## Summary
- Q1 revenue $754.3M (+6% YoY); net income $143M ($0.91 EPS) vs $91.6M ($0.59) prior year.
- FFO $1.82/share, exceeding mid-point guidance; driven by portfolio performance and reinstated accrual accounting.
- Executed 1.2M SF of leases in Q1 (double YoY); including 330K SF renewal at 601 Lexington Ave, NY.
- Agreed to acquire Madison Centre in Seattle for ~$730M; signed 570K SF lease with AstraZeneca in Cambridge, MA.
- FY 2022 guidance: EPS $5.32-$5.42; FFO $7.40-$7.50; Q2 EPS $0.79-$0.81; FFO $1.84-$1.86.

## SEC filing metadata
- accession: 0001656423-22-000018
- form_type: 8-K
- ticker: BXP
- cik: 0001037540
- company_name: BXP, Inc.
- filed_at: 2022-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/0001656423-22-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/bxp-20220502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001656423-22-000018
- JSON: https://secwatch.observer/filing/0001656423-22-000018.json
- Plain text: https://secwatch.observer/filing/0001656423-22-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
